Source link : https://www.newshealth.biz/health-news/science-behind-approved-oud-risk-test-questioned/
About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s risk of developing opioid use disorder (OUD). Clinicians and researchers widely denounced the decision and have since called on the FDA to rescind its approval. Now, new research published […]
Author : News Health
Publish date : 2025-01-29 11:29:03
Copyright for syndicated content belongs to the linked Source.